Xingyu Jiang Selected Research

Dysprosium

9/2021

Biodegradable freestanding rare-earth nanosheets promote multimodal imaging and delivers CRISPR-Cas9 plasmid against tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xingyu Jiang Research Topics

Disease

40	Neoplasms (Cancer) 10/2022 - 10/2012
17	Infections 11/2021 - 01/2016
16	Wounds and Injuries (Trauma) 09/2022 - 09/2012
8	Bacterial Infections (Bacterial Infection) 11/2022 - 08/2016
4	Circulating Neoplastic Cells 01/2022 - 12/2015
4	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2019 - 10/2004
3	Adenocarcinoma of Lung 10/2022 - 12/2015
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
3	Wound Infection (Wound Infections) 09/2020 - 01/2017
2	Epilepsy (Aura) 02/2022 - 09/2020
2	Inflammation (Inflammations) 01/2022 - 09/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 01/2016
2	Thrombosis (Thrombus) 12/2016 - 08/2014
2	Atherosclerosis 09/2014 - 09/2012
2	Dehydration (Water Stress) 01/2013 - 12/2007
1	Ototoxicity 02/2022
1	Starvation 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Glioma (Gliomas) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Hyperplasia 12/2020

Drug/Important Bio-Agent (IBA)

20	GoldIBA 11/2022 - 10/2004
18	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
9	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2017
8	LipidsIBA 02/2022 - 12/2007
7	CelluloseIBA 09/2022 - 03/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2016
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2004
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021 - 01/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 03/2015
4	Biocompatible Materials (Biomaterials)IBA 01/2019 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	Therapeutic UsesIBA 01/2022 - 01/2018
3	Contrast MediaIBA 01/2022 - 10/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 09/2014
3	Small Interfering RNA (siRNA)IBA 01/2017 - 03/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 12/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2015
2	PlatinumIBA 01/2022 - 12/2015
2	matrigelIBA 01/2021 - 01/2011
2	Biological ProductsIBA 01/2021 - 12/2015
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2020 - 01/2020
2	caprolactoneIBA 11/2020 - 01/2017
2	GelatinIBA 11/2020 - 01/2017
2	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 05/2015
2	Indicators and Reagents (Reagents)IBA 12/2017 - 12/2016
2	CarbonIBA 08/2017 - 10/2016
2	ProcalcitoninIBA 08/2017 - 08/2016
2	AntigensIBA 01/2017 - 08/2016
2	Messenger RNA (mRNA)IBA 01/2016 - 12/2015
1	osimertinibIBA 10/2022
1	Gefitinib (Iressa)FDA Link 10/2022
1	MethyltransferasesIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Peptides (Polypeptides)IBA 02/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 02/2022
1	NitrogenIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Circular RNAIBA 01/2022
1	InterleukinsIBA 01/2022
1	Annexin A5IBA 01/2022
1	artenimol (dihydroartemisinin)IBA 01/2022
1	Chemokine CCL3IBA 01/2022
1	dysprosium oxide (dysprosia)IBA 01/2022
1	ferric oxide (iron oxide)IBA 01/2022
1	AcidsIBA 11/2021
1	Fibroins (Fibroin)IBA 10/2021
1	DysprosiumIBA 09/2021
1	ErbiumIBA 09/2021
1	Ointments (Pastes)IBA 07/2021
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 02/2021
1	Cytochrome P-450 CYP2C19IBA 02/2021
1	Cytochrome P-450 CYP2C9IBA 02/2021
1	LigandsIBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2021
1	Galectin 1 (LGALS1)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Singlet OxygenIBA 12/2020
1	Coloring Agents (Dyes)IBA 12/2020
1	Hydroxyl RadicalIBA 12/2020

Therapy/Procedure

22	Therapeutics 02/2022 - 12/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
4	Lab-On-A-Chip Devices 07/2019 - 10/2012
2	Catheters 01/2022 - 01/2020
2	Precision Medicine 12/2020 - 12/2019
2	Photochemotherapy (Photodynamic Therapy) 12/2020 - 01/2020
1	Oral Administration 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020